Loss of Function TGFBR2 Variant as a Contributing Factor in Generalized Pustular Psoriasis and Adult-Onset Immunodeficiency

Genes (Basel). 2022 Dec 29;14(1):103. doi: 10.3390/genes14010103.

Abstract

Background: Generalized pustular psoriasis (GPP; MIM 614204) is a rare multisystemic autoinflammatory disease, characterized by episodes of acute generalized erythema and scaling developed with the spread of numerous sterile pustules. Adult-onset immunodeficiency syndrome (AOID) with anti-interferon-γ autoantibodies is an immunodeficiency disorder associated with disruptive IFN-γ signaling.

Methods: Clinical examination and whole exome sequencing (WES) were performed on 32 patients with pustular psoriasis phenotypes and 21 patients with AOID with pustular skin reaction. Histopathological and immunohistochemical studies were performed.

Results: WES identified four Thai patients presenting with similar pustular phenotypes-two with a diagnosis of GPP and the other two with AOID-who were found to carry the same rare TGFBR2 frameshift mutation c.458del; p.Lys153SerfsTer35, which is predicted to result in a marked loss of functional TGFBR2 protein. The immunohistochemical studied showed overexpression of IL1B, IL6, IL17, IL23, IFNG, and KRT17, a hallmark of psoriatic skin lesions. Abnormal TGFB1 expression was observed in the pustular skin lesion of an AOID patient, suggesting disruption to TGFβ signaling is associated with the hyperproliferation of the psoriatic epidermis.

Conclusions: This study implicates disruptive TGFBR2-mediated signaling, via a shared truncating variant, c.458del; p.Lys153SerfsTer35, as a "predisposing risk factor" for GPP and AOID.

Keywords: TGFBR2 mutation; adult-onset immunodeficiency syndrome; anti-interferon-γ autoantibody; generalized pustular psoriasis; predisposing risk factor; pustular skin reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interleukins / genetics
  • Primary Immunodeficiency Diseases* / pathology
  • Psoriasis* / genetics
  • Psoriasis* / pathology
  • Receptor, Transforming Growth Factor-beta Type II / genetics
  • Skin / pathology
  • Skin Diseases, Vesiculobullous* / pathology

Substances

  • Interleukins
  • Receptor, Transforming Growth Factor-beta Type II
  • TGFBR2 protein, human

Grants and funding

This work was supported by the Genomics Thailand Research Grant of the Health Systems Research Institute (HSRI) and the Chiang Mai University Faculty of Medicine Research Fund, grant no. 001-2565.